Propranolol and its current status in cardiovascular disorders
Propranolol, initially introduced as an antianginal agent, has now established its benefits around a wide spectrum of medical disorders ranging from the field of cardiology, psychiatry, gastroenterology, neurology, etc. Owing to its action at multiple receptor sites, propranolol exerts several central and peripheral effects. Of particular note is its role in cardiac illnesses which has been redefined win the current era of cardioselective betablockers. This article highlights the current evidence for the benefits of propranolol in cardiovascular diseases and aims to remind physicians about the subset of cardiac patients in which this drug is still profoundly useful.
The history: Journey to a Nobel Prize: